Follow
Nicole Pinto
Nicole Pinto
Verified email at uwo.ca
Title
Cited by
Cited by
Year
Self-assembly enhances the strength of fibers made from vimentin intermediate filament proteins
N Pinto, FC Yang, A Negishi, MC Rheinstädter, TE Gillis, DS Fudge
Biomacromolecules 15 (2), 574-581, 2014
442014
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition
KM Ruicci, N Pinto, MI Khan, J Yoo, K Fung, D MacNeil, JS Mymryk, ...
Oral oncology 84, 95-103, 2018
372018
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
F Ghasemi, M Black, F Vizeacoumar, N Pinto, KM Ruicci, CCSH Le, ...
Oncotarget 8 (42), 71512, 2017
342017
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ...
Molecular oncology 13 (10), 2160-2177, 2019
302019
Exploiting high-throughput cell line drug screening studies to identify candidate therapeutic agents in head and neck cancer
AC Nichols, M Black, J Yoo, N Pinto, A Fernandes, B Haibe-Kains, ...
BMC Pharmacology and Toxicology 15, 1-10, 2014
282014
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
F Ghasemi, SD Prokopec, D MacNeil, N Mundi, SF Gameiro, C Howlett, ...
JCI insight 4 (1), 2019
272019
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
N Pinto, M Black, K Patel, J Yoo, JS Mymryk, JW Barrett, AC Nichols
Journal of oncology 2014, 2014
252014
A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
KM Ruicci, J Meens, RX Sun, G Rizzo, N Pinto, J Yoo, K Fung, D MacNeil, ...
International Journal of Cancer 145 (8), 2100-2106, 2019
242019
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
N Pinto, SD Prokopec, F Vizeacoumar, K Searle, M Lowerison, KM Ruicci, ...
PLoS One 13 (11), e0207152, 2018
202018
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
N Mundi, SD Prokopec, F Ghasemi, A Warner, K Patel, D MacNeil, ...
Cancers of the head & neck 4, 1-8, 2019
142019
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
F Ghasemi, M Black, RX Sun, F Vizeacoumar, N Pinto, KM Ruicci, J Yoo, ...
Oncotarget 9 (40), 26064, 2018
142018
The control of anaplastic thyroid carcinoma cell lines by oncolytic poxviruses
N Mundi, S Um, J Yoo, G Rizzo, M Black, N Pinto, DA Palma, K Fung, ...
Virus research 190, 53-59, 2014
142014
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
KM Ruicci, J Meens, P Plantinga, W Stecho, N Pinto, J Yoo, K Fung, ...
Journal of Experimental & Clinical Cancer Research 39, 1-18, 2020
132020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
N Pinto, SD Prokopec, F Ghasemi, J Meens, KM Ruicci, IM Khan, N Mundi, ...
PLoS One 15 (9), e0239315, 2020
132020
Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype
N Pinto, KM Ruicci, MI Khan, MH Shaikh, YFP Zeng, J Yoo, K Fung, ...
Journal of Otolaryngology-Head & Neck Surgery 51 (1), 7, 2022
82022
Detection of circulating tumor DNA in patients with thyroid nodules
KB Patel, N Cormier, J Fowler, A Partridge, J Theurer, M Black, N Pinto, ...
International journal of endocrinology 2021, 2021
82021
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer
M Black, F Ghasemi, RX Sun, W Stecho, A Datti, J Meens, N Pinto, ...
Oral Oncology 101, 104529, 2020
72020
Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma
JA Theurer, W Stecho, J Yoo, K Kwan, B Wehrli, V Harry, M Black, N Pinto, ...
Pathology & Oncology Research 22, 35-40, 2016
52016
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ...
Molecular Oncology 14 (1), 230, 2020
22020
Feasibility of real-time personalized patient-derived Tumorgraft® models for guiding systemic treatment in recurrent and/or metastatic head and neck cancer patients
MD Black, A Berger, N Pinto, J Yoo, K Fung, D MacNeil, DA Palma, ...
Cancer Research 80 (16_Supplement), 1112-1112, 2020
12020
The system can't perform the operation now. Try again later.
Articles 1–20